These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 18636179)

  • 1. Rhodamine 123 efflux in human subpopulations of hematopoietic stem cells: comparison between bone marrow, umbilical cord blood and mobilized peripheral blood CD34+ cells.
    Wagner-Souza K; Diamond HR; Ornellas MH; Gomes BE; Almeida-Oliveira A; Abdelhay E; Bouzas LF; Rumjanek VM
    Int J Mol Med; 2008 Aug; 22(2):237-42. PubMed ID: 18636179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
    Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
    Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of immunophenotype of hematopoietic stem/progenitor cells in human umbilical cord blood with flow cytometry and its significance].
    Guo R; Ma B; Zou D
    Zhonghua Xue Ye Xue Za Zhi; 2001 Aug; 22(8):426-8. PubMed ID: 11718095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.
    Maurillo L; Del Poeta G; Venditti A; Buccisano F; Battaglia A; Santinelli S; Caravita T; Epiceno AM; Del Moro B; Tamburini A; Picardi A; Suppo G; Catalano G; Bruno A; Amadori S
    Haematologica; 2001 Mar; 86(3):237-43. PubMed ID: 11255269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifactorial analysis of umbilical cord blood, adult bone marrow and mobilized peripheral blood progenitors using the improved ML-IC assay.
    Theunissen K; Verfaillie CM
    Exp Hematol; 2005 Feb; 33(2):165-72. PubMed ID: 15676210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of adhesion molecules on CD34(+) hematopoietic precursor cells from normal human bone marrow, cord blood and mobilized blood].
    Xiong Y; Teng A; Kong J; Wang J; Yang K; Shen T
    Zhonghua Xue Ye Xue Za Zhi; 2001 Jun; 22(6):285-7. PubMed ID: 11877084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD34+ cells homing: quantitative expression of adhesion molecules and adhesion of CD34+ cells to endothelial cells exposed to shear stress.
    Gigant C; Latger-Cannard V; Bensoussan D; Fawzi S; Feugier P; Bordigoni P; Stoltz JF
    Biorheology; 2003; 40(1-3):189-95. PubMed ID: 12454404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human umbilical cord blood: immunophenotypic heterogeneity of CD34+ hematopoietic progenitor cells.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Zendoli F; Carotenuto M
    Haematologica; 1996; 81(5):404-9. PubMed ID: 8952152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth factors mobilize CXCR4 low/negative primitive hematopoietic stem/progenitor cells from the bone marrow of nonhuman primates.
    Mahmud N; Patel H; Hoffman R
    Biol Blood Marrow Transplant; 2004 Oct; 10(10):681-90. PubMed ID: 15389434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of down regulating of p27 on the activity of hematopoietic progenitor cells derived from umbilical cord blood and bone marrow ex vivo].
    Li L; Li XX; Cheng T
    Zhonghua Xue Ye Xue Za Zhi; 2005 Feb; 26(2):90-3. PubMed ID: 15921625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor receptor profile of CD34 cells in normal bone marrow, cord blood and mobilized peripheral blood.
    De Waele M; Renmans W; Asosingh K; Vander Gucht K; Van Riet I
    Eur J Haematol; 2004 Mar; 72(3):193-202. PubMed ID: 14962238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential study on the in vivo homing potential of human hematopoietic stem/progenitor cells from different sources in xenotransplanted NOD/SCID mouse model].
    Yang Z; Lu SH; Li YH; Liu B; Wang HJ; Jia HR; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):391-5. PubMed ID: 17939405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the phenotype and clonogenicity of normal CD34+ cells from umbilical cord blood, granulocyte colony-stimulating factor-mobilized peripheral blood, and adult human bone marrow.
    Steen R; Tjønnfjord GE; Egeland T
    J Hematother; 1994; 3(4):253-62. PubMed ID: 7537606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Residual placental blood and bone marrow as sources of hematopoietic stem cells for allogenic stem cell transplantation. Comparative analysis of hematopoietic potential].
    Köhler A; Häfer R; Müller A; Zintl F
    Klin Padiatr; 1995; 207(4):215-8. PubMed ID: 7564155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of retroviral transduction efficiency in CD34+ cells derived from bone marrow versus G-CSF-mobilized or G-CSF plus stem cell factor-mobilized peripheral blood in nonhuman primates.
    Hematti P; Tuchman S; Larochelle A; Metzger ME; Donahue RE; Tisdale JF
    Stem Cells; 2004; 22(6):1062-9. PubMed ID: 15536196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mobilized peripheral blood CD34+ cells express more amphotropic retrovirus receptor than bone marrow CD34+ cells.
    Bregni M; Di Nicola M; Siena S; Belli N; Milanesi M; Shammah S; Ravagnani F; Gianni AM
    Haematologica; 1998 Mar; 83(3):204-8. PubMed ID: 9573673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unique biological properties and application potentials of CD34+ CD38- stem cells from various sources.
    Wang TY; Chang SJ; Chang MD; Wang HW
    Taiwan J Obstet Gynecol; 2009 Dec; 48(4):356-69. PubMed ID: 20045756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic characterization and preclinical production of human lineage-negative cells for regenerative stem cell therapy.
    Strunk D; Rohde E; Lanzer G; Linkesch W
    Transfusion; 2005 Mar; 45(3):315-26. PubMed ID: 15752148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.